| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
222,500 |
|
|
Indirect Shares
|
85,622 |
|
|
| Direct
Value |
$10,410,775 |
|
|
|
Indirect Value
|
$4,006,253 |
|
|
| Total
Shares |
308,122 |
|
|
| Total
Value |
$14,417,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -300.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-08-08 |
222,500 |
2024-08-08 |
85,622 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
AS |
$211.83 |
$4,273,311 |
D/D |
(20,000) |
182,989 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-06-15 |
4 |
AS |
$125.39 |
$3,792,804 |
D/D |
(30,000) |
187,719 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-08-05 |
4 |
AS |
$126.67 |
$3,675,939 |
D/D |
(28,500) |
187,719 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-29 |
4 |
AS |
$60.50 |
$3,025,573 |
D/D |
(50,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-12-10 |
4 |
AS |
$141.17 |
$2,845,782 |
D/D |
(20,000) |
169,189 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-12-06 |
4 |
D |
$69.17 |
$2,615,871 |
D/D |
(37,818) |
261,335 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-07-27 |
4 |
AS |
$75.64 |
$1,897,747 |
D/D |
(25,000) |
290,279 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-08-29 |
4 |
AS |
$66.14 |
$1,671,084 |
D/D |
(25,000) |
290,279 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-05-30 |
4 |
AS |
$63.61 |
$1,621,894 |
D/D |
(25,000) |
387,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-09-28 |
4 |
AS |
$64.58 |
$1,615,160 |
D/D |
(25,000) |
290,279 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-15 |
4 |
AS |
$79.94 |
$1,607,177 |
D/D |
(20,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-06-29 |
4 |
AS |
$61.42 |
$1,539,862 |
D/D |
(25,000) |
290,279 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-15 |
4 |
AS |
$71.97 |
$1,449,628 |
D/D |
(20,000) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-11-28 |
4 |
AS |
$53.58 |
$1,350,827 |
D/D |
(25,000) |
290,279 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-01-27 |
4 |
AS |
$50.60 |
$1,286,798 |
D/D |
(25,000) |
369,111 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-04-25 |
4 |
AS |
$50.50 |
$1,266,638 |
D/D |
(25,000) |
387,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
AS |
$62.50 |
$1,250,058 |
D/D |
(20,000) |
187,377 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-02-27 |
4 |
AS |
$47.71 |
$1,206,243 |
D/D |
(25,000) |
375,988 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-04-15 |
4 |
AS |
$59.88 |
$1,173,232 |
D/D |
(19,582) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
AS |
$63.57 |
$1,117,266 |
D/D |
(17,275) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-01 |
4 |
AS |
$67.28 |
$1,040,400 |
D/D |
(15,000) |
148,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-12-28 |
4 |
AS |
$40.81 |
$1,023,290 |
D/D |
(25,000) |
369,111 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-12-05 |
4 |
D |
$52.26 |
$1,013,896 |
D/D |
(19,401) |
310,878 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-01-29 |
4 |
OE |
$19.12 |
$956,000 |
D/D |
50,000 |
237,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-17 |
4 |
AS |
$46.00 |
$920,000 |
D/D |
(20,000) |
165,801 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
